ARTH - Arch Therapeutics, Inc.

0
0.000   inf%

Share volume: 16,744
Last Updated: 12-23-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
-1.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 0%
Dept financing 25%
Liquidity 1%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-100.00%
1 Year
-100.00%
2 Year
-100.00%
Key data
Stock price
$0.00
P/E Ratio 
0.00
DAY RANGE
$0.00 - $0.00
EPS 
-$1.04
52 WEEK RANGE
$0.00 - $0.21
52 WEEK CHANGE
-$100.00
MARKET CAP 
3.804 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO:
Region: US
Website: archtherapeutics.com
Employees: 10
IPO year: 2013
Issue type:
Market: OTCM
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking.

Recent news